How the aging cardiovascular system changes, why polypharmacy creates unique risks, how blood pressure targets require individualization in older patients, and the goals-of-care conversations that are part of complete cardiac care.
Most landmark cardiovascular trials enrolled patients aged 55-65. The average cardiac patient in clinical practice is in their 70s or 80s, often with frailty, multiple comorbidities, cognitive changes, and a very different risk-benefit profile than the trial participants who established the guidelines. Applying protocols without modification can harm older adults.
This guide covers what actually changes about cardiac care after 65 — physiologically, pharmacologically, and in terms of what the goals of care should be.
Arterial stiffening, diastolic dysfunction, reduced chronotropic reserve, arrhythmia susceptibility, orthostatic hypotension, and reduced drug clearance.
5 specific polypharmacy risks — drug interactions, medication cascade, fall risk, renal toxicity, adherence complexity — with practical solutions.
Why the <130/80 target requires modification in frail patients and those with orthostatic hypotension.
BP drop on standing that causes falls — underdiagnosed, medication-related, and entirely addressable.
Advance care planning, ICD deactivation discussion, functional goals — the conversations complete cardiac care must include.
Age is not a barrier — older adults benefit from supervised rehabilitation as much or more than younger patients.
“The goal of cardiac care in an 80-year-old is not to give them the same treatment as a 55-year-old. It is to understand what matters most to them, what their body can safely tolerate, and to deploy every tool we have in service of those individual goals. Age is never a reason to give up — but it is always a reason to individualize.”
The guide for older adults with heart disease — and the family members who support them.
Get Older Adults Heart Guide — $37